KC-1456
ADAR (adenosine deaminase RNA specific; important alias: ADAR1) encodes adenosine deaminase acting on RNA 1, an interferon-inducible enzyme that catalyzes adenosine-to-inosine (A-to-I) RNA editing on double-stranded RNA substrates. The p150 isoform is the full-length, interferon-inducible form that localizes to both cytoplasm and nucleus. ADAR1 plays critical roles in innate immune regulation, preventing aberrant activation of the interferon response by self RNA, and is implicated in cancer progression and autoimmune diseases such as Aicardi-Goutières syndrome. It represents an emerging therapeutic target in oncology and immunology.
| Catalog Number | KC-1456 |
|---|---|
| Cell Line Name | 293T-ISRE-Luc2-ADAR1-P150 Cell Line |
| NCBI/UniProt Accession Number | NM_001111.5 |
| Host Cell Line | 293T |
| Description | HEK293T reporter cell line stably expressing ISRE-driven Luc2 reporter and human ADAR1-P150, designed for interferon pathway and ADAR1 functional studies |
| Quantity | One vial of frozen cells (≥2×106 cells) |
| Stability | Stable in culture over a minimum of 10 passages |
| Application | Drug screening and biological assays |
| Freezing Medium | 70% DMEM+20% FBS+10% DMSO |
| Propagation Medium | DMEM+10%FBS+140μg/mL Hygromycin B |
| Selection Marker | Hygromycin B |
| Morphology | Epithelial-like |
| Subculture | Split at a ratio of 1:5–1:8 every 2–3 days |
| Incubation | 37°C with 5% CO₂ |
| Storage | Liquid nitrogen immediately upon receiving |
| Doubling Time | Estimated 16–31 hours |
| Mycoplasma Status | Negative |
| In Vivo Validation | NA |